BMJ 1996; 312 doi: (Published 06 April 1996) Cite this as: BMJ 1996;312:866
  1. None Given

    US hurries through cancer drugs: The US administration is planning to streamline the Food and Drug Administration's rules to reduce the time lag for new drugs for cancer treatment to get on to the market. The new rules mean that companies need to show that their products only shrink tumours rather than lengthen the survival of cancer patients. The drug agency will also accept evidence of the drug's effectiveness from other countries …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial